DCTY1102 / Beijing DCTY Biotech - LARVOL DELTA

C2025-009-01: A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=18 | Not yet recruiting | Sponsor: Beijing DCTY Biotech Co.,Ltd. | N=110 ➔ 18 | Trial completion date: May 2028 ➔ Aug 2028 | Trial primary completion date: May 2028 ➔ Aug 2028

Enrollment change • Trial completion date • Trial primary completion date • Colorectal Cancer • Lung Cancer • Oncology • Pancreatic Cancer • Solid Tumor • KRAS • NRAS

A Study of DCTY1102 Injection in Patients With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=110 | Not yet recruiting | Sponsor: Beijing DCTY Biotech Co.,Ltd.

New P1 trial • Colorectal Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • KRAS